A novel role of extracellular nucleotides in valve calcification: A potential target for atorvastatin

Circulation

Volumn 114, Issue SUPPL. 1, 2006, Pages

  Osman, Lana ^a   Chester, Adrian H ^a   Amrani, Mohamed ^a   Yacoub, Magdi H ^a,c   Smolenski, Ryszard T ^a,b  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Adenosine; Enzymes; Statins; Valves

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; ALKALINE PHOSPHATASE; ATORVASTATIN; BIOLOGICAL MARKER; NUCLEOTIDE; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; 5' NUCLEOTIDASE; ADENOSINE 5' O (3 THIOTRIPHOSPHATE); ADENOSINE 5'-O-(3-THIOTRIPHOSPHATE); ADENOSINE TRIPHOSPHATASE; APYRASE; DRUG DERIVATIVE; HEPTANOIC ACID DERIVATIVE; PURINE P2 RECEPTOR; PYRROLE DERIVATIVE;

AORTA VALVE; AORTA VALVE DISEASE; ARTERY CALCIFICATION; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG TARGETING; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; HYPOTHESIS; IMMUNOCYTOCHEMISTRY; NUCLEOTIDE METABOLISM; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE; UPREGULATION; AGED; AORTA VALVE STENOSIS; CALCINOSIS; CELL CULTURE; CYTOLOGY; DRUG EFFECT; DRUG SCREENING; ENZYMOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SECOND MESSENGER;

5'-NUCLEOTIDASE; ADENOSINE; ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; AGED; ALKALINE PHOSPHATASE; AORTIC VALVE; AORTIC VALVE STENOSIS; APYRASE; BIOLOGICAL MARKERS; CALCINOSIS; CELL DIFFERENTIATION; CELLS, CULTURED; DRUG EVALUATION, PRECLINICAL; HEPTANOIC ACIDS; HUMANS; MIDDLE AGED; OSTEOBLASTS; PYRROLES; RECEPTORS, PURINERGIC P2; SECOND MESSENGER SYSTEMS;

EID: 33747190902     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.001214     Document Type: Article

References (21)

1. Chikwe J, Walther A, Pepper J. The surgical management of aortic valve disease. Br J Cardiol. 2003;10:453-461.
2. Mohler ER, III, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation. 2001;103:1522-1528.
3. Gallagher JA, Buckley KA. Expression and function of P2 receptors in bone. J Musculoskelet Neuronal Interact. 2002 ;2:432-439.
4. Bowler WB, Buckley KA, Gartland A, Hipskind RA, Bilbe G, Gallagher JA. Extracellular nucleotide signaling: a mechanism for integrating local and systemic responses in the activation of bone remodeling. Bone. 2001;28:507-512.
5. Gartland A, Buckley KA, Hipskind RA, Perry MJ, Tobias JH, Buell G, Chessell I, Bowler WB, Gallagher JA. Multinucleated osteoclast formation in vivo and in vitro by P2X7 receptor-deficient mice. Crit Rev Eukaryot Gene Expr. 2003;13(2-4):243-53.
6. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature. 2001 December 20;414(6866):916-20.
7. Taylor PM, Batten P, Brand NJ, Thomas PS, Yacoub MH. The cardiac valve interstitial cell. Int J Biochem Cell Biol. 2003;35:113-118.
8. Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation. 2001;104:2205-2209.
9. Taylor PM, Allen SP, Yacoub MH. Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium and skin. J Heart Valve Dis. 2000;9:150-158.
10. Smolenski RT, Lachno DR, Ledingham SJ, Yacoub MH. Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation. J Chromatogr. 1990;527:414-420.
11. Bowler WB, Buckley KA, Gartland A, Hipskind RA, Bilbe G, Gallagher JA. Extracellular nucleotide signaling: a mechanism for integrating local and systemic responses in the activation of bone remodeling. Bone. 2001;28:507-512.
12. Kaden JJ, Bickelhaupt S, Grobholz R, Haase KK, Sarikoc A, Kilic R, Brueckmann M, Lang S, Zahn I, Vahl C, Hagl S, Dempfle CE, Borggrefe M. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification. J Mol Cell Cardiol. 2004;36:57-66.
13. Rajamannan NM, Subramaniam M, Rickard D, Stock SR, Donovan J, Springett M, Orszulak T, Fullerton DA, Tajik AJ, Bonow RO, Spelsberg T. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation. 2003;107:2181-2184.
14. Mathieu P, Voisine P, Pepin A, Shetty R, Savard N, Dagenais F. Calcification of human valve interstitial cells is dependent on alkaline phosphatase activity. J Heart Valve Dis. 2005;14:353-357.
15. Ely SW, Berne RM. Protective effects of adenosine in myocardial ischemia. Circulation. 1992;85:893-904.
16. Zimmermann H. Two novel families of ectonucleotidases: molecular structures, catalytic properties and a search for function. Trends Pharmacol Sci. 1999;20:231-236.
17. Morikawa S, Takabe W, Mataki C, Kanke T, Itoh T, Wada Y, Izumi A, Saito Y, Hamakubo T, Kodama T. The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells. J Atheroscler Thromb. 2002;9:178-183.
18. Cilla DD, Jr., Whitfield LR, Gibson DM, Sedman AJ, Posvar EL. Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects. Clin Pharmacol Ther. 1996;60:687-695.
19. Moura ML, Zamorano J, Ramos S, Azevedo L, Rocha-Joncalves, Rajamannan N. Rosuvastatin affecting aortic valve endothelium (RAAVE) to slow the progression of aortic stenosis. Circulation. 2005; Supplement II: 112-117.
20. Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, Boon NA. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005;352:2389-2397.
21. Rajamannan NM, Subramaniam M, Springett M, Sebo TC, Niekrasz M, McConnell JP, Singh RJ, Stone NJ, Bonow RO, Spelsberg TC. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation. 2002;105:2660-2665.